Anixa Biosciences (ANIX) Income from Continuing Operations (2010 - 2026)
Anixa Biosciences' Income from Continuing Operations came in at -$2.63 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$2.28 million a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Anixa Biosciences reported Income from Continuing Operations of -$10.16 million; for FY2025 (ended Oct 31, 2025), it came in at -$11.03 million.
- Going back by fiscal year, Income from Continuing Operations was -$12.7 million in FY2024, -$9.93 million in FY2023, -$13.77 million in FY2022 and -$13.13 million in FY2021.
- The five-year range for quarterly Income from Continuing Operations is -$4.08 million (fiscal Q4 2021) to -$2.28 million (fiscal Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | -2.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -2.63 Mn |
| Apr 30, 2026 | -2.54 Mn |
| Oct 31, 2025 | -2.72 Mn |
| Jul 31, 2025 | -2.28 Mn |
| Apr 30, 2025 | -2.81 Mn |
| Jan 31, 2025 | -3.21 Mn |
| Oct 31, 2024 | -2.91 Mn |
| Jul 31, 2024 | -3.32 Mn |
| Apr 30, 2024 | -3.18 Mn |
| Jan 31, 2024 | -3.29 Mn |
| Oct 31, 2023 | -2.72 Mn |
| Jul 31, 2023 | -2.55 Mn |
| Apr 30, 2023 | -2.31 Mn |
| Jan 31, 2023 | -2.35 Mn |
| Oct 31, 2022 | -3.53 Mn |
| Jul 31, 2022 | -2.78 Mn |
| Apr 30, 2022 | -3.59 Mn |
| Jan 31, 2022 | -3.88 Mn |
| Oct 31, 2021 | -4.08 Mn |
| Jul 31, 2021 | -4.39 Mn |
API Access
Anixa Biosciences Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();